A number of leading banks are set to report their second quarter 2024 earnings results over this week and the next. JPMorgan Chase & Co. (NYSE: JPM), Wells Fargo & Company (NYSE: WFC), and Citigroup Inc. (NYSE: C) are scheduled to report their financial results on Friday, July 12, before markets open.
Goldman Sachs (NYSE: GS) will report its Q2 results on Monday, July 15 while Morgan Stanley (NYSE: MS) will report its results on Tuesday, July 16. Here’s a look at what to expect from the Q2 reports:
JPMorgan
Analysts are projecting earnings of $4.26 per share on revenue of $39.5 billion for JPMorgan for the second quarter of 2024. This compares to earnings of $4.75 per share on revenue of $41.3 billion reported in the same period a year ago. In the first quarter of 2024, the company delivered EPS of $4.44 on revenue of $41.9 billion.
Wells Fargo
The consensus estimate is for earnings of $1.28 per share on revenue of $20.23 billion for Wells Fargo in Q2 2024, which compares to earnings of $1.25 per share on revenue of $20.5 billion reported in the prior-year quarter. In Q1 2024, Wells Fargo reported earnings of $1.20 per share on revenue of $20.8 billion.
Citigroup
Analysts are predicting EPS of $1.41 on revenue of $20.08 billion for Citigroup in Q2 2024. This compares to EPS of $1.33 on revenue of $19.4 billion reported in Q2 2023. In Q1 2024, the company reported EPS of $1.58 on revenue of $21.1 billion.
Goldman Sachs
Goldman Sachs is expected to report earnings of $8.61 per share on revenue of $11.64 billion in the second quarter of 2024. This compares to EPS of $3.08 on revenue of $10.9 billion reported in Q2 2023. In Q1 2024, the company reported EPS of $11.58 on revenue of $14.2 billion.
Morgan Stanley
Analysts expect Morgan Stanley to report earnings of $1.65 per share on revenue of $14.3 billion in Q2 2024. This compares to EPS of $1.24 on revenue of $13.5 billion reported in Q2 2023. In Q1 2024, the company reported EPS of $2.02 on revenues of $15.1 billion.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
